Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;32(12):1637-1642.
doi: 10.1016/j.annonc.2021.08.1994. Epub 2021 Sep 1.

Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy

Affiliations
Free article

Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy

J Remon et al. Ann Oncol. 2021 Dec.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure JCS reports that he is on the Board of directors for Hookipa Pharma, a former full-time employee of AstraZeneca from September 2017 to December 2019 and has shares in Relay Therapeutics and Gritstone Bio. JR reports receipt of honoraria to institute for consultancy, advisory boards and/or lectures from AstraZeneca, Bristol Myers Squibb (BMS), Boehringer Ingelheim, Merck Sharp & Dohme (MSD), OSE-Immunotherapeutics, Pfizer, Roche. SP reports consultation/advisory roles for AbbVie, Amgen, AstraZeneca, Bayer, BeiGene, Biocartis, BioInvent, Blueprint Medicines, Boehringer Ingelheim, BMS, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, Elsevier, F. Hoffmann-La Roche/Genentech, Foundation Medicine, Illumina, Incyte, IQVIA, Janssen, Medscape, MSD, Merck Serono, Merrimack, Mirati, Novartis, PharmaMar, Phosplatin Therapeutics, Pfizer, Regeneron, Sanofi, Seattle Genetics, Takeda, Vaccibody; talk in a company's organised public event: AstraZeneca, Boehringer Ingelheim, BMS, e-cancer, Eli Lilly, F. Hoffmann-La Roche/Genentech, Illumina, Medscape, MSD, Novartis, PER, Pfizer, Prime, RTP, Sanofi, Takeda; receipt of grants/research support as (sub)investigator in trials (institutional financial support for clinical trials) sponsored by Amgen, AstraZeneca, Biodesix, Boehringer Ingelheim, BMS, Clovis, F. Hoffmann-La Roche/Genentech, GlaxoSmithKline, Illumina, Lilly, MSD, Merck Serono, Mirati, Novartis, Pfizer, Phosplatin Therapeutics.

MeSH terms